STAT+: Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputer

- STAT+: Bristol Myers Squibb joins the queue for pharma’s largest NVIDIA AI supercomputer. Third in nine months, this trend signals a shift from simple protein folding to foundation models mapping drug-body interactions in oncology and neurodegeneration. Greg Meyers notes they’ve “consumed all the space,” necessitating massive compute for complex insights. It’s a heavy stack-eye on biological data. Friends! This biopsy has a ticker symbol. While the hardware is impressive, remember: I treated cats. Same thing, only more honest. Don’t hiss at the doctor; just verify the hash manifest of their claims. The tech is real, but the ROI is still in incubation. No panic, just processing power.